1. A smoking cessation programme for current and recent ex‐smokers following diagnosis of a potentially curable cancer. Issue 9 (16th September 2016) Authors: Ong, J.; Plueckhahn, I.; Cruickshank, D.; Churilov, L.; Mileshkin, L. Journal: Internal medicine journal Issue: Volume 46:Issue 9(2016) Page Start: 1089 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1202 Discussing and prescribing expensive unfunded anticancer drugs in Australia. (September 2015) Authors: Karikios, D.; Mileshkin, L.; Martin, A.; Ferraro, D.; Stockler, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2773 ALLOCATE: sorting ovarian cancer patients into treatment categories based on genetic characteristics of their tumours. (September 2015) Authors: Kondrashova, O.; Lunke, S.; Mileshkin, L.; Alsop, K.; Scott, C.; Hamilton, A.; Ananda, S.; Quinn, M.; Bowtell, D.; McNally, O.; Cowie, T.; Wakefield, M.; Hsu, A.; Taylor, G.; Waring, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0298 Toxicity and patient-reported symptoms after 3D-conformal or intensity-modulated pelvic radiotherapy. (August 2021) Authors: Wortman, B.; Post, C.; Powell, M.; Khaw, P.; Fyles, A.; D'Amico, R.; Haie-Meder, C.; Jurgenliemk-Schulz, I.; McCormack, M.; Do, V.; Katsaros, D.; Bessette, P.; Baron, M.; Nout, R.; Whitmarsh, K.; Mileshkin, L.; Lutgens, L.; Kitchener, H.; Brooks, S.; Nijman, H. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial. Issue 3 (March 2022) Authors: Khaw, P.; Do, V.; Lim, K.; Cunninghame, J.; Dixon, J.; Vassie, J.; Bailey, M.; Johnson, C.; Kahl, K.; Gordon, C.; Cook, O.; Foo, K.; Fyles, A.; Powell, M.; Haie-Meder, C.; D'Amico, R.; Bessette, P.; Mileshkin, L.; Creutzberg, C.L.; Moore, A. Journal: Clinical oncology Issue: Volume 34:Issue 3(2022) Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC-0369: Long-Term Quality of Life after (chemo)radiotherapy for high-risk Endometrial Cancer in PORTEC-3. (November 2020) Authors: Post, C.; De Boer, S.M.; Powell, M.E.; Mileshkin, L.; Katsaros, D.; Bessette, P.; Haie-Meder, C.; Ottevanger, P.B.; Ledermann, J.A.; Khaw, P.; D'Amico, R.; Fyles, A.; Baron, M.; Kitchener, H.C.; Nijman, H.W.; Lutgens, L.C.; Brooks, S.; Jürgenliemk-Schulz, I.M.; Feeney, A.; Nout, R.A. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial. Issue 1 (December 2016) Authors: Gray, H.; Benigno, B.; Berek, J.; Chang, J.; Mason, J.; Mileshkin, L.; Mitchell, P.; Moradi, M.; Recio, F.; Michener, C.; Secord, A.; Tchabo, N; Chan, J.; Young, J.; Kohrt, H.; Gargosky, S.; Goh, J. Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC-0323: Patterns of recurrence in the randomised PORTEC-3 trial of chemoradiotherapy for endometrial cancer. (April 2018) Authors: De Boer, S.M.; Powell, M.E.; Mileshkin, L.; Katsaros, D.; Bessette, P.; Haie-Meder, C.; Ottevanger, P.B.; Ledermann, J.A.; Khaw, P.; Colombo, A.; Fyles, A.; Baron, M.H.; Jürgenliemk-Schulz, I.M.; Kitchener, H.C.; Nijman, H.W.; Wilson, G.; Kolodziej, I.; Carinelli, S.; Lutgens, L.C.H.W.; Smit, V.T... Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Weighing up the benefits and harms of a new anti‐cancer drug: a survey of Australian oncologists. Issue 8 (August 2015) Authors: Chim, L.; Salkeld, G.; Stockler, M. R.; Mileshkin, L. Journal: Internal medicine journal Issue: Volume 45:Issue 8(2015) Page Start: 834 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial. Issue 1 (21st June 2016) Authors: Gray, H. J.; Benigno, B.; Berek, J.; Chang, J.; Mason, J.; Mileshkin, L.; Mitchell, P.; Moradi, M.; Recio, F. O.; Michener, C. M.; Secord, A. Alvarez; Tchabo, N E.; Chan, J. K.; Young, J.; Kohrt, H.; Gargosky, S. E.; Goh, J. C. Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗